To characterize the muscarinic cholinergic re ceptors on the endothelium of human cerebral arteries, isometric tension measurement and receptor autoradio graphic studies were performed. Acetylcholine (ACh) in duced dose-dependent relaxation of human cerebral ar teries precontracted by 10-5 M serotonin, with an EC s o of 1.9 ± 0.6 x 10-6 M (n = 7). The relaxation was abol ished by 10 -s M hemoglobin. Autoradiography, using the muscarinic antagonist [3HJpropylbenzilylcholine mus-
Histological studies have revealed a rich innerva tion of cholinesterase-stained or choline acetyl transferase (ChAT)-stained neurons in cerebral ar teries of humans (Edvinsson et a!., 1976) , monkeys (Denn and Stone, 1976) , and other species (Iwayama et a!., 1970; Borodulya and Pletchkova, 1976) . Intraarterial infusion of acetylcholine (ACh) or cholinergic agonists increases the cerebral blood flow, and this increase is blocked by atropine (Scremin et a!., 1973; D'Alecy and Rose, 1977; Aubineau et a!., 1980) . Radioligand binding studies have demonstrated muscarinic cholinergic receptor sites in bovine (Estrada and Krause, 1982; Shimo hama et a!., 1985) , rat (Grammas et a!., 1983) , dog (Tsukahara et aI., 1986) , and human (Ferrari-DiLeo and Potter, 1985; Tsukahara et aI., 1986 ) cerebral arteries. These findings suggest the existence of cholinergic innervation and muscarinic cholinergic receptors in the cerebral arteries. tard, demonstrated the high density of muscarinic cholin ergic receptors on the endothelial cells of human cerebral arteries, especially on the luminal surface of the endothe lium. These findings suggest that ACh-induced relaxation mediated by muscarinic cholinergic receptors on the en dothelium has a physiological function in human cerebral arteries. Key Words: Autoradiography-Endothelium Human cerebral artery-Muscarinic receptors.
Since Furchgott and Zawadzki (1980) reported that muscarinic receptors on the vascular endothe lium mediate the release of an endothelium-derived relaxing factor(s) (EDRF) in various arteries, it has been thought that there are muscarinic cholinergic receptors not only on the vascular smooth muscle, but also on the vascular endothelium (Furchgott and Zawadzki, 1980; Lee, 1982; Angus et aI., 1983; Furchgott, 1983; Fujiwara et aI., 1986) . The dual responses of vasodilation and vasoconstriction in duced by ACh in various arteries, including cere bral arteries, have been explained by the existence of muscarinic cholinergic receptors on the endothe lium and the smooth muscle (Edvinsson et a!., 1977; Lee, 1982; Furchgott, 1983; Tsukahara et aI., 1986) . There is, however, no direct evidence regarding the existence of the receptors on endothelium, and little is known about the relative distribution of these re ceptors in the different regions of the vessels, en dothelium, and smooth muscle.
The present study was designed to characterize muscarinic cholinergic receptors in human cerebral arteries, especially those on the endothelium, using isometric tension measurements and receptor auto radiography. eH]Propylbenzilylcholine mustard ([3H]PrBCM), the irreversible muscarinic antago nist, was used as the ligand.
MATERIALS AND METHODS

Human cerebral arteries
Cerebral arterial specimens (cortical branches of ante rior cerebral or middle cerebral artery with a diameter of -1.0 mm) of five patients were obtained during surgical lobectomy of the frontal or temporal lobe. The arterial specimens were carefully removed from the lobectomized brain and placed in ice-cold modified Krebs bicarbonate solution [composition (roM): NaCI 120, KCI 4.5, MgS04 1.0, NaHC0 3 27.0, KH2P04 1.0, CaCl 2 2.5, and dextrose 10.0]. The other specimens were obtained from two au topsy cases. Cerebral arteries were carefully removed from the brain �4 h after death and rinsed in cold Krebs solution. Clinical data on the patients are summarized in Table 1 .
Tension measurement
Ring segments of human cerebral artery (3 mm in length) from lobectomized brains were prepared and sus pended between two L-shaped stainless-steel rods in an organ bath with 10 ml working volume of Krebs solution, which was aerated with 95% 02/5% CO2, The pH of the solution ranged from 7.4 to 7.5. One rod was connected to a force-displacement transducer (FT.03; Grass Instru ment Co., Quincy, MA, U.S.A.). The preparations were allowed to equilibrate at 37"C for 60 min before use. Rest ing tension was adjusted to 400 mg. The contractile force was recorded isometrically using the force-displacement transducer and was displayed on a Soltec 3418 polygraph (Soitec Co., Sun Valley, CA, U.S.A.). To confirm appro priate contractile activity in each specimen, the contrac tile response to 40 roM KCl was first obtained in each ring segment. Only the specimens that showed good response to 40 roM KCl were used for the relaxation study. Pre contractions were induced by 1O�5 M serotonin. The re laxing effect of ACh (10�8-10� 4 M) was measured when the serotonin-elicited contraction reached a plateau (�5 min). Relaxation was expressed as a percentage of the amplitude of contraction.
Muscarinic cholinergic receptor autoradiography
Muscarinic cholinergic receptors in human cerebral ar teries were labeled with [3H]PrBCM using the method previously reported (Tsukahara et aI., 1989) . The isolated human cerebral artery from lobectomized cases or au topsy cases was rinsed in cold Krebs solution and was frozen with OCT compound (Tissue-Tek; Miles, Elkhart, IN, U.S.A.) onto coated brass chucks by slow immersion in methylbutane cooled by liquid nitrogen. After warming to cryostat temperature (-20°C), the artery was sec tioned at a thickness of 10 fLm and thaw-mounted onto chrome-alumlge1atin-coated slides. The slides were pre incubated in Krebs solution with (nonspecific binding) or without (total binding) 1O�5 M unlabeled PrBCM. Fol lowing the 30-min preincubation, eH]PrBCM was added, producing a final concentration of 5 nM. After the incu bation was performed at room temperature for 30 min, it was terminated by transferring the slides into cold Krebs solution. After washing for 90 min with three changes of cold Krebs solution, the sections were rinsed in distilled water. The sections were air-dried and stored overnight in sealed boxes at 4°C until they were covered with NTB2 photoemulsion (Kodak, Rochester, NY, U.S.A.). After 1 week of exposure, the autoradiogram was de veloped. The slides were processed in Kodak D-19 at 20°C for 3 min and then fixed for 2 min.
The [3H]PrBCM binding sites, both on the endothelium and on the smooth muscle of human cerebral arteries, were identified by cresyl violet staining of the slides.
Drugs
[3H]PrBCM (48.0 Ci/mmol) and unlabeled PrBCM were purchased from Amersham (Arlington Heights, IL, U.S.A.). Serotonin was dissolved in Krebs solution be fore use, such that volumes of <0.1 ml were added to the organ bath.
RESULTS
Tension measurement
ACh (10� 8 _1O� 5 M) evoked dose-dependent re laxation in the human cerebral arteries precon tracted by 10 � 5 M serotonin. Figure 1 shows a typ ical example of the dose-dependent relaxation of human cerebral arteries by ACh (Case 1). As pre sented in Fig. 2 , the EC 5 0 of ACh was 1.9 ± 0.6 x 10-6 M (n = 7) in human cerebral arteries. The relaxations induced by ACh were inhibited by 10-5 M hemoglobin. grains, however, was not as great at the luminal sUlface without endothelial cells (arrows, Fig. 3B ).
Muscarinic cholinergic receptor autoradiography
As clearly demonstrated in Figs. 4 and 5, the high density of the muscarinic receptors was observed especially on the luminal surface of the endotheli um. These bindings were displaced by a high con centration of cold PrBCM (10 -5 M) ( Figs. 4B and  5B) .
DISCUSSION
In the present study, we demonstrate that (a) ACh induced a dose-dependent relaxation of human cerebral arteries and (b) a high density of muscarin ic cholinergic receptors is located on the cerebral endothelium. The EC50 of ACh, 1.9 ± 0.6 x 10-6 M in this study, is comparable to that of human cere bral arteries in the previous study (Tsukahara et aI., 1986) , in which the EC 5 0 was reported to be 6.1 ± 0.2 x 10-6 M. The lower value of the ECso in this study might be explained by (a) differences in the specimens (in the previous study autopsy speci mens were used, whereas in this study intraopera tive fresh specimens were used) and (b) different artery preparations (the previous study used heli cally cut specimens and there is a possibility that some damage of endothelial cells might have oc curred during the preparation). We also demonstrate the rich accumulation of eH]PrBCM binding sites on the endothelium of hu man cerebral arteries. PrBCM is a relatively selec tive and irreversible muscarinic antagonist intro duced by Gill and Rang (1966) . Specificity for the muscarinic cholinergic receptor has been confirmed in guinea pig small intestine (Gill and Rang, 1966) , rat brain (Rotter et aI., 1979) , and rabbit thoracic aorta (Tsukahara et aI., 1989) . According to bio chemical characterization of eH]PrBCM binding in rabbit thoracic aorta, the 5 nM concentration of eH]PrBCM and the incubation time of 30 min were confirmed to be sufficient to obtain a good specific and nonspecific binding ratio and the binding was displaced by a high concentration of atropine or cold PrBCM. These results are in accordance with previous studies (Gill and Rang, 1966; Rotter et aI., 1979; Tsukahara et aI., 1989) , showing that eH]PrBCM is muscanOlC receptor specific. Al though we could not confirm the biochemical char acterization of eH]PrBCM binding in human cere bral arteries because of the limited availability of human specimens, eH]PrBCM binding was dis placed by a high concentration of cold PrBCM on human cerebral arteries, suggesting the binding is also specific for muscarinic receptors. Microscopic analysis of the autoradiograms dem onstrated that the muscarinic receptors seem more densely located on the luminal side of the endothe lium than on the abluminal side, indicating a possi bility of heterogeneous distribution of muscarinic receptors in the vascular endothelium. Intracellular distribution of the receptors should be investigated more thoroughly.
At present two sites in the arteries are thought to have muscarinic cholinergic receptors: (a) the smooth muscle layer and (b) the endothelium. His tochemical studies have demonstrated that ChAT or cholinesterase activity, markers of cholinergic innervation, reached the outer border of the smooth muscle layer of the arteries (Iwayama et ai., 1970; FIG. 4 . A: Autoradiogram of the basilar artery (Case 6) viewed in dark field: total binding. The rich accumulation of the [3H]propylbenzilylcholine mustard binding sites was evi dent on the luminal side of the endothelial layer; some bind ing sites were also seen on the smooth muscle layer. B: Au toradiogram of the nonspecific binding to the serial arterial section in dark field. Nonspecific binding sites were seen both on the endothelial layer and on the smooth muscle layer. The number of silver grains in the smooth muscle layer is not that different between A and B. The number of grains on the endothelium, however, is much higher in A than in B. ET, endothelial layer; SM, smooth muscle layer. Bars repre sent 50 fLm. binding sites at higher magnification: total binding (same specimen as in Fig. 4A,B) . Binding sites were seen on the lu minal side of the artery. B: Nonspecific [3H]PrBCM binding on the endothelium (same specimen as in Fig. 4B ). Silver grains on the luminal side of the endothelium are evident. Grains on the smooth muscle cannot be seen because they are out of the plane of focus. ET, endothelium; SM, smooth muscle. Bars represent 10 fLm. Borodulya and Pletchkova, 1976; Denn and Stone, 1976; Edvinsson et ai., 1976) . It is natural to sup pose the existence of cholinergic receptors on the smooth muscle as a postsynaptic site of the inner vation. Since Furchgott and Zawadzki (1980) first documented that endothelial cells have an obliga tory role in the relaxation of arterial smooth muscle by ACh and that the relaxation is mediated by mus carinic cholinergic receptors, the existence of mus carinic receptors on the vascular endothelium has been suggested. The relative distribution of the re ceptors in the arteries, however, has not been suf ficiently studied. Hynes et ai. (1986) reported that after endothelial denudation of rabbit ear artery, the affinity for muscarinic receptors was not changed, but the density of the receptors was increased. Con sidering the result, they suggested the existence of a different type of muscarinic receptor on the endo thelium. A recent autoradiographic study by Stephenson and Summers (1987) demonstrated that muscarinic receptors were located on the adventitial and smooth muscle layers of rabbit pulmonary artery, but not on the endothelial layer. There are two ex planations for these seemingly different results. First, they used (eH]QNB) as a ligand for labeling muscarinic receptors. Since [3H]QNB is a revers ible ligand, rinsing after incubation would wash off most of the bound eH]QNB. Actually, the grain densities in their study were very low even in the smooth muscle layer. Second, the regional and spe cies differences of the arterial specimens would also cause different results.
We demonstrated the existence of muscarinic re ceptors on both the smooth muscle layer and the endothelium in rabbit thoracic aorta (Tsukahara et aI., 1989) . However, the density of muscarinic re ceptors on the endothelium was low in rabbit basilar arteries (Tsukahara et aI., 1988) . The distribution of the muscarinic receptors between the endothelial layer and the smooth muscle layer might be varied among regions and species of arteries. Regarding cholinergic innervation of human cerebral arteries, Edvinsson et aI. (1976) reported that, unlike in cat cerebral arteries (Edvinsson et aI., 1977) , contrac tile responses were not obtained with various con centrations of ACh. In the previous study, the same tendency was confirmed when comparing the re sults of human and dog cerebral arteries (Tsukahara et aI., 1986) . The different character of the cholin ergic innervation and the muscarinic cholinergic re ceptors in the cerebral arteries might be a cause of this species difference. Indeed, the density of mus carinic cholinergic receptors and ChAT activity were lower in human than in dog cerebral arteries (Tsukahara et aI., 1986) . The values obtained for the arterial homogenates in that study may represent the values for the smooth muscle layer. This repre sents a far more dominant volume than the endo thelium. These findings suggest that cholinergic in nervation and muscarinic receptors are not located as densely on the smooth muscle layer of human cerebral arteries.
EDRF has been proposed to have an important role in regulating the local blood flow, including ce rebral blood flow (Haller et aI., 1987; Rosenblum et aI., 1987) . However, this role has not been suffi ciently investigated in human cerebral arteries. ACh-induced relaxation of human cerebral arteries was inhibited by hemoglobin, indicating the relax-J Cereb Blood Flow Me/ab, Vol. 9, No. 6, 1989 ation was also mediated by EDRF. The high density of muscarinic receptors on the endothelium and the large amount of ACh-induced vasodilation suggest that EDRF may also have an important role in the regulation of human cerebral blood flow.
